Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats

Synaptic dysfunction is hypothesised to play a key role in schizophrenia pathogenesis. Here, using [11C]UCB-J PET, the authors show for the first time in vivo that levels of the synaptic marker protein SV2A are reduced in schizophrenia and unaffected by antipsychotic treatment in a rat model.

Guardado en:
Detalles Bibliográficos
Autores principales: Ellis Chika Onwordi, Els F. Halff, Thomas Whitehurst, Ayla Mansur, Marie-Caroline Cotel, Lisa Wells, Hannah Creeney, David Bonsall, Maria Rogdaki, Ekaterina Shatalina, Tiago Reis Marques, Eugenii A. Rabiner, Roger N. Gunn, Sridhar Natesan, Anthony C. Vernon, Oliver D. Howes
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Q
Acceso en línea:https://doaj.org/article/d2e6a5e593d0405db0ad2d55f3b35447
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d2e6a5e593d0405db0ad2d55f3b35447
record_format dspace
spelling oai:doaj.org-article:d2e6a5e593d0405db0ad2d55f3b354472021-12-02T14:42:47ZSynaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats10.1038/s41467-019-14122-02041-1723https://doaj.org/article/d2e6a5e593d0405db0ad2d55f3b354472020-01-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-14122-0https://doaj.org/toc/2041-1723Synaptic dysfunction is hypothesised to play a key role in schizophrenia pathogenesis. Here, using [11C]UCB-J PET, the authors show for the first time in vivo that levels of the synaptic marker protein SV2A are reduced in schizophrenia and unaffected by antipsychotic treatment in a rat model.Ellis Chika OnwordiEls F. HalffThomas WhitehurstAyla MansurMarie-Caroline CotelLisa WellsHannah CreeneyDavid BonsallMaria RogdakiEkaterina ShatalinaTiago Reis MarquesEugenii A. RabinerRoger N. GunnSridhar NatesanAnthony C. VernonOliver D. HowesNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-11 (2020)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Ellis Chika Onwordi
Els F. Halff
Thomas Whitehurst
Ayla Mansur
Marie-Caroline Cotel
Lisa Wells
Hannah Creeney
David Bonsall
Maria Rogdaki
Ekaterina Shatalina
Tiago Reis Marques
Eugenii A. Rabiner
Roger N. Gunn
Sridhar Natesan
Anthony C. Vernon
Oliver D. Howes
Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats
description Synaptic dysfunction is hypothesised to play a key role in schizophrenia pathogenesis. Here, using [11C]UCB-J PET, the authors show for the first time in vivo that levels of the synaptic marker protein SV2A are reduced in schizophrenia and unaffected by antipsychotic treatment in a rat model.
format article
author Ellis Chika Onwordi
Els F. Halff
Thomas Whitehurst
Ayla Mansur
Marie-Caroline Cotel
Lisa Wells
Hannah Creeney
David Bonsall
Maria Rogdaki
Ekaterina Shatalina
Tiago Reis Marques
Eugenii A. Rabiner
Roger N. Gunn
Sridhar Natesan
Anthony C. Vernon
Oliver D. Howes
author_facet Ellis Chika Onwordi
Els F. Halff
Thomas Whitehurst
Ayla Mansur
Marie-Caroline Cotel
Lisa Wells
Hannah Creeney
David Bonsall
Maria Rogdaki
Ekaterina Shatalina
Tiago Reis Marques
Eugenii A. Rabiner
Roger N. Gunn
Sridhar Natesan
Anthony C. Vernon
Oliver D. Howes
author_sort Ellis Chika Onwordi
title Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats
title_short Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats
title_full Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats
title_fullStr Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats
title_full_unstemmed Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats
title_sort synaptic density marker sv2a is reduced in schizophrenia patients and unaffected by antipsychotics in rats
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/d2e6a5e593d0405db0ad2d55f3b35447
work_keys_str_mv AT ellischikaonwordi synapticdensitymarkersv2aisreducedinschizophreniapatientsandunaffectedbyantipsychoticsinrats
AT elsfhalff synapticdensitymarkersv2aisreducedinschizophreniapatientsandunaffectedbyantipsychoticsinrats
AT thomaswhitehurst synapticdensitymarkersv2aisreducedinschizophreniapatientsandunaffectedbyantipsychoticsinrats
AT aylamansur synapticdensitymarkersv2aisreducedinschizophreniapatientsandunaffectedbyantipsychoticsinrats
AT mariecarolinecotel synapticdensitymarkersv2aisreducedinschizophreniapatientsandunaffectedbyantipsychoticsinrats
AT lisawells synapticdensitymarkersv2aisreducedinschizophreniapatientsandunaffectedbyantipsychoticsinrats
AT hannahcreeney synapticdensitymarkersv2aisreducedinschizophreniapatientsandunaffectedbyantipsychoticsinrats
AT davidbonsall synapticdensitymarkersv2aisreducedinschizophreniapatientsandunaffectedbyantipsychoticsinrats
AT mariarogdaki synapticdensitymarkersv2aisreducedinschizophreniapatientsandunaffectedbyantipsychoticsinrats
AT ekaterinashatalina synapticdensitymarkersv2aisreducedinschizophreniapatientsandunaffectedbyantipsychoticsinrats
AT tiagoreismarques synapticdensitymarkersv2aisreducedinschizophreniapatientsandunaffectedbyantipsychoticsinrats
AT eugeniiarabiner synapticdensitymarkersv2aisreducedinschizophreniapatientsandunaffectedbyantipsychoticsinrats
AT rogerngunn synapticdensitymarkersv2aisreducedinschizophreniapatientsandunaffectedbyantipsychoticsinrats
AT sridharnatesan synapticdensitymarkersv2aisreducedinschizophreniapatientsandunaffectedbyantipsychoticsinrats
AT anthonycvernon synapticdensitymarkersv2aisreducedinschizophreniapatientsandunaffectedbyantipsychoticsinrats
AT oliverdhowes synapticdensitymarkersv2aisreducedinschizophreniapatientsandunaffectedbyantipsychoticsinrats
_version_ 1718389597393649664